Skip to main content

Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs

Goldman Sachs analyst Jami Rubin upgraded Johnson & Johnson to Neutral with an unchanged price target of $134.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.